Heyholder
‹ Activism Filings

KoBioLabs, Inc. Q3 revenue KRW 20.4 billion, loss of KRW 3.2 billion from main business

KoBioLabs, Inc.· Periodic Report

AI summary · Not investment advice

Gobiolab sold KRW 20.4 billion worth in Q3 and lost KRW 3.2 billion from its main business, versus a KRW 0.4 billion loss a year earlier.

Operating profit · 3 months

KRW -3.2 billion

Key facts

Revenue (3 months)
KRW 20.4 billion
Net income (3 months)
KRW -2.5 billion
Period
Q3 (cumulative 2026.01.01 ~ 2026.09.30)
Revenue (prior-year 3 months)
KRW 19.3 billion
Revenue (year to date)
KRW 61.5 billion
Operating profit (prior-year 3 months)
KRW -422.6 millionOperating loss
Operating profit (year to date)
KRW -7.8 billionOperating loss
Net income (prior-year 3 months)
KRW 855.8 millionNet income in the prior-year same period
Net income (year to date)
KRW -6.6 billionQuarterly net loss

Commentary

AI commentary · Not investment advice

What happened

Gobiolab filed its quarterly report with consolidated results for the third quarter of this year. Sales for the three months were KRW 20.4 billion. That is 6.2% more than the same period a year earlier. It is 6.2% less than the previous quarter. Cumulative sales for the year so far were KRW 61.5 billion.

In the company's terms

Operating profit (profit from the core business) for the three months was a loss of KRW 3.2 billion. A year earlier, the same period had an operating loss of KRW 0.4 billion. The cumulative operating loss for the year so far was KRW 7.8 billion.

What changes for shareholders

Net income (the final profit after taxes and other items) for the three months was a loss of KRW 2.5 billion. A year earlier, the same period had a net profit of KRW 0.9 billion, so it turned to a loss. The cumulative net loss for the year so far was KRW 6.6 billion.

Comments

No comments yet

Comments from shareholders will appear here.